Tenet Healthcare's shares closed up 1.8% following Q1 2026 results, reflecting a neutral to mildly positive investor response as the company delivered results above its own expectations and reaffirmed full-year guidance. Investors appeared comfortable with steady hospital margins, solid ASC growth, and ongoing productivity measures, despite ongoing payer mix headwinds and unchanged guidance.

• Q1 net operating revenues were $5.4 billion with consolidated adjusted EBITDA of $1.16 billion, representing a 21.6% margin.
• USPI segment generated $484 million in adjusted EBITDA, up 6% year over year, with 5.3% same-facility revenue growth and double-digit volume growth in total joint replacements at ASCs.
• Hospital segment posted $678 million in adjusted EBITDA (16.7% margin); exchange admissions dropped about 10% YoY due to declines in exchange coverage, but expense initiatives offset margin pressure.
• The company reaffirmed its full-year 2026 guidance, citing a dynamic operating environment and unchanged Medicaid revenue assumptions.
• Tenet repurchased 1.35 million shares for $318 million in Q1, with further share buybacks planned for 2026.